BioMed Research International / 2021 / Article / Tab 1 / Research Article
[Retracted] High-Throughput Screen of Natural Compounds and Biomarkers for NSCLC Treatment by Differential Expression and Weighted Gene Coexpression Network Analysis (WGCNA) Table 1 The list of positive control.
Drug Source (company) Sorafenib Beijing Solarbio Science & Technology Co., Ltd cis-Platinum Beijing Solarbio Science & Technology Co., Ltd Lenvatinib Shanghai Topscience Bio-Technology Co., Ltd Cabozantinib Shanghai Yuanye Bio-Technology Co., Ltd Doxorubicin hydrochloride Shanghai Yuanye Bio-Technology Co., Ltd Gefitinib Shanghai Macklin Biological Co., Ltd Paclitaxel Shanghai Macklin Biological Co., Ltd Docetaxel Shanghai Macklin Biological Co., Ltd Vinorelbine Shanghai Aladdin Reagent Co., Ltd Gemcitabine Beijing OKA Bio-Technology Co., Ltd